Alumis (ALMS) Share-based Compensation (2023 - 2025)
Alumis (ALMS) reported Share-based Compensation of $8.1 million for Q4 2025, up 27.51% year-over-year from $6.4 million in Q4 2024, and down 17.17% quarter-over-quarter from $9.8 million in Q3 2025.
Alumis (ALMS) Share-based Compensation (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Share-based Compensation data on file, last reported at $8.1 million in Q4 2025.
- Share-based Compensation for Q4 2025 came in at $8.1 million, up 27.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $43.5 million (up 123.69% YoY), and the FY2025 annual result was $43.5 million, up 123.69% from the prior year.
- Share-based Compensation eased to $8.1 million in Q4 2025 per ALMS's latest filing, from $9.8 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $18.6 million in Q2 2025 and troughed at $1.9 million in Q2 2023.
- A 3-year average of $6.3 million and a median of $6.4 million in 2024 frame the typical range for Share-based Compensation.
- On a YoY basis, Share-based Compensation climbed as much as 494.8% in 2025 and fell as far as 27.51% in 2025.
- A 3-year view of Share-based Compensation shows it stood at $2.6 million in 2023, then soared by 143.14% to $6.4 million in 2024, then grew by 27.51% to $8.1 million in 2025.
- Business Quant data shows ALMS's Share-based Compensation at $8.1 million in Q4 2025, $9.8 million in Q3 2025, and $18.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 8.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.11 Mn |
| Dec 31, 2025 | 8.11 Mn |
| Sep 30, 2025 | 9.79 Mn |
| Sep 30, 2025 | 9.79 Mn |
| Jun 30, 2025 | 18.64 Mn |
| Jun 30, 2025 | 18.64 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Jun 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | 3.13 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Sep 30, 2023 | 2.27 Mn |